Evidence map›Paper›PMID 27136670›Full record

ArticleEnvironmental research2016

Arsenic in drinking water and prostate cancer in Illinois counties: An ecologic study.

Catherine M Bulka, Rachael M Jones, Mary E Turyk, Leslie T Stayner, Maria Argos

Open access · greenAbstract read
In one paragraph

Article in Environmental research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Arsenic in Drinking Water and Prostate Cancer: A Population-Based Case-Control Study in Northern Chile.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Arsenic-induced prostate cancer: an enigma.Medical oncology (Northwood, London, England) · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Catherine M BulkaUniversity of Illinois at Chicago, School of Public Health, Epidemiology and Biostatistics Division, 1603 W. Taylor Street, Chicago, IL 60612, United States. Electronic address: cbulka2@uic.edu.
Rachael M JonesUniversity of Illinois at Chicago, School of Public Health, Environmental and Occupational Health Sciences Division, 2121W. Taylor Street, Chicago, IL 60612, United States. Electronic address: rjones25@uic.edu.
Mary E TurykUniversity of Illinois at Chicago, School of Public Health, Epidemiology and Biostatistics Division, 1603 W. Taylor Street, Chicago, IL 60612, United States. Electronic address: mturyk1@uic.edu.
Leslie T StaynerUniversity of Illinois at Chicago, School of Public Health, Epidemiology and Biostatistics Division, 1603 W. Taylor Street, Chicago, IL 60612, United States. Electronic address: lstayner@uic.edu.
Maria ArgosUniversity of Illinois at Chicago, School of Public Health, Epidemiology and Biostatistics Division, 1603 W. Taylor Street, Chicago, IL 60612, United States. Electronic address: argos@uic.edu.
University of Illinois Chicago · US

Funding

Occupational Safety and Health, ERC, University of Illinois at ChicagoT42OH008672 · OH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BUCHANAN, SUSAN NATHALIE · 2005 to 2025
$32.7M
Training in CVD Epidemiology & Related Chronic Diseases in Minority PopulationsT32HL125294 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DAVIGLUS, MARTHA L · 2015 to 2019
$1.3M
NHLBI NIH HHS T32 HL125294NIOSH CDC HHS T42 OH008672
6 · The paper itself

Abstract

backgroundInorganic arsenic is a lung, bladder, and skin carcinogen. One of the major sources of exposure to arsenic is through naturally contaminated drinking water. While positive associations have been observed between arsenic in drinking water and prostate cancer, few studies have explored this association in the United States.

objectivesTo evaluate the association between inorganic arsenic concentrations in community water systems and prostate cancer incidence in Illinois using an ecologic study design.

methodsIllinois Environmental Protection Agency data on arsenic concentrations in drinking water from community water systems throughout the state were linked with county-level prostate cancer incidence data from 2007 to 2011 from the Illinois State Cancer Registry. Incidence rates were indirectly standardized by age to calculate standardized incidence ratios (SIRs) for each county. A Poisson regression model was used to model the association between county-level SIRs and mean arsenic tertile (0.33-0.72, 0.73-1.60, and 1.61-16.23ppb), adjusting for potential confounders.

resultsFor counties with mean arsenic levels in the second tertile, the SIR was 1.05 (95% CI: 0.96-1.16). For counties with mean arsenic levels in the third tertile, the SIR was 1.10 (95% CI: 1.03-1.19). There was a significant linear dose-response relationship observed between mean arsenic levels and prostate cancer incidence (p for trend=0.003).

conclusionsIn this ecologic study, counties with higher mean arsenic levels in community water systems had significantly higher prostate cancer incidence. Individual-level studies of prostate cancer incidence and low-level arsenic exposure are needed.

Indexed as

AdolescentAdultAgedArsenicCarcinogensHumansIllinoisIncidenceMaleMiddle AgedModels, StatisticalProstatic NeoplasmsRegression AnalysisWater Pollutants, ChemicalYoung AdultArsenicCarcinogensWater Pollutants, ChemicalArsenicPoissonProstate cancerSpatial autocorrelationWater

Identifiers

PMID27136670
PMCPMC4874890
OpenAlexW2344485563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.